These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Conjunctival temperature: a measure of ocular decongestant and anti-inflammatory activity. Salem H, Dunn BJ, Loux JJ. Ann Ophthalmol; 1975 Jun; 7(6):819-24. PubMed ID: 1147509 [Abstract] [Full Text] [Related]
9. Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitis. Abelson MB, George MA, Schaefer K, Smith LM. J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):458-64. PubMed ID: 7916020 [Abstract] [Full Text] [Related]
11. Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity. Abelson MB, Spitalny L. Am J Ophthalmol; 1998 Jun; 125(6):797-804. PubMed ID: 9645717 [Abstract] [Full Text] [Related]
17. Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis. Abelson MB, Gomes P, Crampton HJ, Schiffman RM, Bradford RR, Whitcup SM. Clin Ther; 2004 Jan; 26(1):35-47. PubMed ID: 14996516 [Abstract] [Full Text] [Related]